{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:47:40Z","timestamp":1792298860492,"version":"4.4.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T00:00:00Z","timestamp":1666483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T00:00:00Z","timestamp":1666483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM134307"],"award-info":[{"award-number":["R01GM134307"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["K01ES028047"],"award-info":[{"award-number":["K01ES028047"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS126513"],"award-info":[{"award-number":["R01NS126513"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018864","name":"Making Headway Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018864","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100018290","name":"Bear Necessities Pediatric Cancer Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018290","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100003287","name":"Rally Foundation for Childhood Cancer Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100003287","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006058","name":"St. Baldrick's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001445","name":"Alex's Lemonade Stand Foundation for Childhood Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001445","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Diffuse intrinsic pontine glioma (DIPG) is an aggressive incurable brainstem tumor that targets young children. Complete resection is not possible, and chemotherapy and radiotherapy are currently only palliative. This study aimed to identify potential therapeutic agents using a computational pipeline to perform an in silico screen for novel drugs. We then tested the identified drugs against a panel of patient-derived DIPG cell lines. Using a systematic computational approach with publicly available databases of gene signature in DIPG patients and cancer cell lines treated with a library of clinically available drugs, we identified drug hits with the ability to reverse a DIPG gene signature to one that matches normal tissue background. The biological and molecular effects of drug treatment was analyzed by cell viability assay and RNA sequence. In vivo DIPG mouse model survival studies were also conducted. As a result, two of three identified drugs showed potency against the DIPG cell lines Triptolide and mycophenolate mofetil (MMF) demonstrated significant inhibition of cell viability in DIPG cell lines. Guanosine rescued reduced cell viability induced by MMF. In vivo, MMF treatment significantly inhibited tumor growth in subcutaneous xenograft mice models. In conclusion, we identified clinically available drugs with the ability to reverse DIPG gene signatures and anti-DIPG activity in vitro and in vivo. This novel approach can repurpose drugs and significantly decrease the cost and time normally required in drug discovery.<\/jats:p>","DOI":"10.1186\/s40478-022-01463-z","type":"journal-article","created":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T16:31:44Z","timestamp":1666542704000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma"],"prefix":"10.1186","volume":"10","author":[{"given":"Guisheng","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Newbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukitomo","family":"Ishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Chekalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Billy","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin S.","family":"Glicksberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Paithankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amreena","family":"Suri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Nazarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Pacold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Brat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore","family":"Nicolaides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9373-7831","authenticated-orcid":false,"given":"Rintaro","family":"Hashizume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,23]]},"reference":[{"key":"1463_CR1","first-page":"10","volume":"23","author":"AC Allison","year":"1991","unstructured":"Allison AC, Almquist SJ, Muller CD, Eugui EM (1991) In vitro immunosuppressive effects of mycophenolic acid and an ester pro-drug, RS-61443. Transplant Proc 23:10\u201314","journal-title":"Transplant Proc"},{"key":"1463_CR2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/BF00192309","volume":"14","author":"AC Allison","year":"1993","unstructured":"Allison AC, Eugui EM (1993) The design and development of an immunosuppressive drug, mycophenolate mofetil. Springer Semin Immunopathol 14:353\u2013380. https:\/\/doi.org\/10.1007\/BF00192309","journal-title":"Springer Semin Immunopathol"},{"key":"1463_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/s0162-3109(00)00188-0","volume":"47","author":"AC Allison","year":"2000","unstructured":"Allison AC, Eugui EM (2000) Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 47:85\u2013118. https:\/\/doi.org\/10.1016\/s0162-3109(00)00188-0","journal-title":"Immunopharmacology"},{"key":"1463_CR4","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/s0140-6736(75)92661-6","volume":"2","author":"AC Allison","year":"1975","unstructured":"Allison AC, Hovi T, Watts RW, Webster AD (1975) Immunological observations on patients with Lesch-Nyhan syndrome, and on the role of de-novo purine synthesis in lymphocyte transformation. Lancet 2:1179\u20131183. https:\/\/doi.org\/10.1016\/s0140-6736(75)92661-6","journal-title":"Lancet"},{"issue":"528\u201344","key":"1463_CR5","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1016\/j.ccell.2019.09.005","volume":"36","author":"JN Anastas","year":"2019","unstructured":"Anastas JN, Zee BM, Kalin JH, Kim M, Guo R, Alexandrescu S et al (2019) Re-programing chromatin with a bifunctional LSD1\/HDAC inhibitor induces therapeutic differentiation in DIPG. Cancer Cell 36(528\u201344):e10. https:\/\/doi.org\/10.1016\/j.ccell.2019.09.005","journal-title":"Cancer Cell"},{"key":"1463_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11060-011-0796-x","volume":"108","author":"Y Aoki","year":"2012","unstructured":"Aoki Y, Hashizume R, Ozawa T, Banerjee A, Prados M, James CD et al (2012) An experimental xenograft mouse model of diffuse pontine glioma designed for therapeutic testing. J Neurooncol 108:29\u201335. https:\/\/doi.org\/10.1007\/s11060-011-0796-x","journal-title":"J Neurooncol"},{"key":"1463_CR7","doi-asserted-by":"publisher","first-page":"12587","DOI":"10.18632\/oncotarget.3494","volume":"6","author":"SJ Barfeld","year":"2015","unstructured":"Barfeld SJ, Fazli L, Persson M, Marjavaara L, Urbanucci A, Kaukoniemi KM et al (2015) Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer. Oncotarget 6:12587\u201312602. https:\/\/doi.org\/10.18632\/oncotarget.3494","journal-title":"Oncotarget"},{"key":"1463_CR8","doi-asserted-by":"publisher","first-page":"13465","DOI":"10.1074\/jbc.M413347200","volume":"280","author":"C Barsotti","year":"2005","unstructured":"Barsotti C, Pesi R, Giannecchini M, Ipata PL (2005) Evidence for the involvement of cytosolic 5\u2032-nucleotidase (cN-II) in the synthesis of guanine nucleotides from xanthosine. J Biol Chem 280:13465\u201313469. https:\/\/doi.org\/10.1074\/jbc.M413347200","journal-title":"J Biol Chem"},{"key":"1463_CR9","doi-asserted-by":"publisher","first-page":"e77639","DOI":"10.1371\/journal.pone.0077639","volume":"8","author":"KL Barton","year":"2013","unstructured":"Barton KL, Misuraca K, Cordero F, Dobrikova E, Min HD, Gromeier M et al (2013) PD-0332991, a CDK4\/6 inhibitor, significantly prolongs survival in a genetically engineered mouse model of brainstem glioma. PLoS One 8:e77639. https:\/\/doi.org\/10.1371\/journal.pone.0077639","journal-title":"PLoS One"},{"key":"1463_CR10","doi-asserted-by":"publisher","first-page":"173580","DOI":"10.1016\/j.ejphar.2020.173580","volume":"887","author":"J Benjanuwattra","year":"2020","unstructured":"Benjanuwattra J, Chaiyawat P, Pruksakorn D, Koonrungsesomboon N (2020) Therapeutic potential and molecular mechanisms of mycophenolic acid as an anticancer agent. Eur J Pharmacol 887:173580. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173580","journal-title":"Eur J Pharmacol"},{"key":"1463_CR11","doi-asserted-by":"publisher","first-page":"27286","DOI":"10.1016\/S0021-9258(19)74247-1","volume":"268","author":"SF Carr","year":"1993","unstructured":"Carr SF, Papp E, Wu JC, Natsumeda Y (1993) Characterization of human type I and type II IMP dehydrogenases. J Biol Chem 268:27286\u201327290","journal-title":"J Biol Chem"},{"key":"1463_CR12","doi-asserted-by":"publisher","first-page":"16022","DOI":"10.1038\/ncomms16022","volume":"8","author":"B Chen","year":"2017","unstructured":"Chen B, Ma L, Paik H, Sirota M, Wei W, Chua MS et al (2017) Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets. Nat Commun 8:16022. https:\/\/doi.org\/10.1038\/ncomms16022","journal-title":"Nat Commun"},{"key":"1463_CR13","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1053\/j.gastro.2017.02.039","volume":"152","author":"B Chen","year":"2017","unstructured":"Chen B, Wei W, Ma L, Yang B, Gill RM, Chua MS et al (2017) Computational discovery of niclosamide ethanolamine, a repurposed drug candidate that reduces growth of hepatocellular carcinoma cells in vitro and in mice by inhibiting cell division cycle 37 signaling. Gastroenterology 152:2022\u20132036. https:\/\/doi.org\/10.1053\/j.gastro.2017.02.039","journal-title":"Gastroenterology"},{"key":"1463_CR14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV et al (2013) Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform 14:128. https:\/\/doi.org\/10.1186\/1471-2105-14-128","journal-title":"BMC Bioinform"},{"key":"1463_CR15","doi-asserted-by":"publisher","first-page":"605060","DOI":"10.3389\/fphar.2020.605060","volume":"11","author":"Y Chen","year":"2020","unstructured":"Chen Y, Sun L, Xu H, Dong M, Mizuno T, Vinks AA et al (2020) PK\/PD Study of mycophenolate mofetil in children with systemic lupus erythematosus to inform model-based precision dosing. Front Pharmacol 11:605060. https:\/\/doi.org\/10.3389\/fphar.2020.605060","journal-title":"Front Pharmacol"},{"key":"1463_CR16","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1002\/hep4.1559","volume":"4","author":"YC Chong","year":"2020","unstructured":"Chong YC, Toh TB, Chan Z, Lin QXX, Thng DKH, Hooi L et al (2020) Targeted inhibition of purine metabolism is effective in suppressing hepatocellular carcinoma progression. Hepatol Commun 4:1362\u20131381. https:\/\/doi.org\/10.1002\/hep4.1559","journal-title":"Hepatol Commun"},{"key":"1463_CR17","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1093\/neuonc\/nox021","volume":"19","author":"KJ Cohen","year":"2017","unstructured":"Cohen KJ, Jabado N, Grill J (2017) Diffuse intrinsic pontine gliomas-current management and new biologic insights. Is there a glimmer of hope? Neuro Oncol 19:1025\u20131034. https:\/\/doi.org\/10.1093\/neuonc\/nox021","journal-title":"Neuro Oncol"},{"key":"1463_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nm.4306","volume":"23","author":"SM Corsello","year":"2017","unstructured":"Corsello SM, Bittker JA, Liu Z, Gould J, McCarren P, Hirschman JE et al (2017) The drug repurposing hub: a next-generation drug library and information resource. Nat Med 23:405\u2013408. https:\/\/doi.org\/10.1038\/nm.4306","journal-title":"Nat Med"},{"key":"1463_CR19","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s11060-020-03641-2","volume":"149","author":"M DeWire","year":"2020","unstructured":"DeWire M, Fuller C, Hummel TR, Chow LML, Salloum R, de Blank P et al (2020) A phase I\/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG). J Neurooncol 149:511\u2013522. https:\/\/doi.org\/10.1007\/s11060-020-03641-2","journal-title":"J Neurooncol"},{"key":"1463_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S et al (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29:15\u201321. https:\/\/doi.org\/10.1093\/bioinformatics\/bts635","journal-title":"Bioinformatics"},{"key":"1463_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1365-2125.2012.04305.x","volume":"75","author":"HJ Downing","year":"2013","unstructured":"Downing HJ, Pirmohamed M, Beresford MW, Smyth RL (2013) Paediatric use of mycophenolate mofetil. Br J Clin Pharmacol 75:45\u201359. https:\/\/doi.org\/10.1111\/j.1365-2125.2012.04305.x","journal-title":"Br J Clin Pharmacol"},{"key":"1463_CR22","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1126\/science.aao4750","volume":"360","author":"MG Filbin","year":"2018","unstructured":"Filbin MG, Tirosh I, Hovestadt V, Shaw ML, Escalante LE, Mathewson ND et al (2018) Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq. Science 360:331\u2013335. https:\/\/doi.org\/10.1126\/science.aao4750","journal-title":"Science"},{"key":"1463_CR23","first-page":"251","volume-title":"Pathobiology of human disease","author":"AL Gaffo","year":"2014","unstructured":"Gaffo AL (2014) Crystal diseases. In: McManus LM, Mitchell RN (eds) Pathobiology of human disease. Academic Press, San Diego, pp 251\u2013306"},{"key":"1463_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.trim.2010.04.002","volume":"23","author":"MT Gandolfo","year":"2010","unstructured":"Gandolfo MT, Jang HR, Bagnasco SM, Ko GJ, Agreda P, Soloski MJ et al (2010) Mycophenolate mofetil modifies kidney tubular injury and Foxp3+ regulatory T cell trafficking during recovery from experimental ischemia-reperfusion. Transpl Immunol 23:45\u201352. https:\/\/doi.org\/10.1016\/j.trim.2010.04.002","journal-title":"Transpl Immunol"},{"key":"1463_CR25","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nm.3855","volume":"21","author":"CS Grasso","year":"2015","unstructured":"Grasso CS, Tang Y, Truffaux N, Berlow NE, Liu L, Debily MA et al (2015) Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nat Med 21:555\u2013559. https:\/\/doi.org\/10.1038\/nm.3855","journal-title":"Nat Med"},{"key":"1463_CR26","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/nm.3716","volume":"20","author":"R Hashizume","year":"2014","unstructured":"Hashizume R, Andor N, Ihara Y, Lerner R, Gan H, Chen X et al (2014) Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma. Nat Med 20:1394\u20131396. https:\/\/doi.org\/10.1038\/nm.3716","journal-title":"Nat Med"},{"key":"1463_CR27","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.2017.75.9308","volume":"36","author":"LM Hoffman","year":"2018","unstructured":"Hoffman LM, Veldhuijzen van Zanten SEM, Colditz N, Baugh J, Chaney B, Hoffmann M et al (2018) Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of diffuse intrinsic pontine glioma (DIPG): a collaborative report from the international and european society for pediatric oncology DIPG registries. J Clin Oncol 36:1963\u20131972. https:\/\/doi.org\/10.1200\/JCO.2017.75.9308","journal-title":"J Clin Oncol"},{"key":"1463_CR28","doi-asserted-by":"publisher","first-page":"5572","DOI":"10.1158\/1078-0432.Ccr-18-3890","volume":"25","author":"H Katagi","year":"2019","unstructured":"Katagi H, Louis N, Unruh D, Sasaki T, He X, Zhang A et al (2019) Radiosensitization by histone H3 demethylase inhibition in diffuse intrinsic pontine glioma. Clin Cancer Res 25:5572\u20135583. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-18-3890","journal-title":"Clin Cancer Res"},{"key":"1463_CR29","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1093\/neuonc\/noab009","volume":"23","author":"H Katagi","year":"2021","unstructured":"Katagi H, Takata N, Aoi Y, Zhang Y, Rendleman EJ, Blyth GT et al (2021) Therapeutic targeting of transcriptional elongation in diffuse intrinsic pontine glioma. Neuro Oncol 23:1348\u20131359. https:\/\/doi.org\/10.1093\/neuonc\/noab009","journal-title":"Neuro Oncol"},{"key":"1463_CR30","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","volume":"124","author":"DA Khuong-Quang","year":"2012","unstructured":"Khuong-Quang DA, Buczkowicz P, Rakopoulos P, Liu XY, Fontebasso AM, Bouffet E et al (2012) K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol 124:439\u2013447. https:\/\/doi.org\/10.1007\/s00401-012-0998-0","journal-title":"Acta Neuropathol"},{"key":"1463_CR31","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/s41556-019-0363-9","volume":"21","author":"S Kofuji","year":"2019","unstructured":"Kofuji S, Hirayama A, Eberhardt AO, Kawaguchi R, Sugiura Y, Sampetrean O et al (2019) IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma. Nat Cell Biol 21:1003\u20131014. https:\/\/doi.org\/10.1038\/s41556-019-0363-9","journal-title":"Nat Cell Biol"},{"key":"1463_CR32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN (2011) RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinform 12:323. https:\/\/doi.org\/10.1186\/1471-2105-12-323","journal-title":"BMC Bioinform"},{"key":"1463_CR33","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw0064","author":"GL Lin","year":"2019","unstructured":"Lin GL, Wilson KM, Ceribelli M, Stanton BZ, Woo PJ, Kreimer S et al (2019) Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aaw0064","journal-title":"Sci Transl Med"},{"issue":"520\u201337","key":"1463_CR34","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/j.ccell.2017.08.017","volume":"32","author":"A Mackay","year":"2017","unstructured":"Mackay A, Burford A, Carvalho D, Izquierdo E, Fazal-Salom J, Taylor KR et al (2017) Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma. Cancer Cell 32(520\u201337):e5. https:\/\/doi.org\/10.1016\/j.ccell.2017.08.017","journal-title":"Cancer Cell"},{"key":"1463_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/molpharm.121.000331","volume":"101","author":"SA Misek","year":"2022","unstructured":"Misek SA, Newbury PA, Chekalin E, Paithankar S, Doseff AI, Chen B et al (2022) Ibrutinib blocks YAP1 activation and reverses BRAF inhibitor resistance in melanoma cells. Mol Pharmacol 101:1\u201312. https:\/\/doi.org\/10.1124\/molpharm.121.000331","journal-title":"Mol Pharmacol"},{"key":"1463_CR36","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1200\/JCO.2013.50.4910","volume":"31","author":"PG Morris","year":"2013","unstructured":"Morris PG, Correa DD, Yahalom J, Raizer JJ, Schiff D, Grant B et al (2013) Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome. J Clin Oncol 31:3971\u20133979. https:\/\/doi.org\/10.1200\/JCO.2013.50.4910","journal-title":"J Clin Oncol"},{"key":"1463_CR37","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ccell.2017.09.014","volume":"32","author":"M Pathania","year":"2017","unstructured":"Pathania M, De Jay N, Maestro N, Harutyunyan AS, Nitarska J, Pahlavan P et al (2017) H3.3(K27M) cooperates with Trp53 loss and PDGFRA gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas. Cancer Cell 32:684-700 e9. https:\/\/doi.org\/10.1016\/j.ccell.2017.09.014","journal-title":"Cancer Cell"},{"key":"1463_CR38","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1200\/jco.2011.35.5677","volume":"29","author":"BS Paugh","year":"2011","unstructured":"Paugh BS, Broniscer A, Qu C, Miller CP, Zhang J, Tatevossian RG et al (2011) Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma. J Clin Oncol 29:3999\u20134006. https:\/\/doi.org\/10.1200\/jco.2011.35.5677","journal-title":"J Clin Oncol"},{"key":"1463_CR39","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.18632\/oncotarget.13385","volume":"8","author":"ZY Pessetto","year":"2017","unstructured":"Pessetto ZY, Chen B, Alturkmani H, Hyter S, Flynn CA, Baltezor M et al (2017) In silico and in vitro drug screening identifies new therapeutic approaches for Ewing sarcoma. Oncotarget 8:4079\u20134095","journal-title":"Oncotarget"},{"key":"1463_CR40","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nm.4296","volume":"23","author":"A Piunti","year":"2017","unstructured":"Piunti A, Hashizume R, Morgan MA, Bartom ET, Horbinski CM, Marshall SA et al (2017) Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas. Nat Med 23:493\u2013500. https:\/\/doi.org\/10.1038\/nm.4296","journal-title":"Nat Med"},{"key":"1463_CR41","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3171\/2018.10.Peds18377","volume":"23","author":"IF Pollack","year":"2019","unstructured":"Pollack IF, Agnihotri S, Broniscer A (2019) Childhood brain tumors: current management, biological insights, and future directions. J Neurosurg Pediatr 23:261\u2013273. https:\/\/doi.org\/10.3171\/2018.10.Peds18377","journal-title":"J Neurosurg Pediatr"},{"key":"1463_CR42","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.omto.2021.01.011","volume":"20","author":"Y Qin","year":"2021","unstructured":"Qin Y, Zheng X, Gao W, Wang B, Wu Y (2021) Tumor microenvironment and immune-related therapies of head and neck squamous cell carcinoma. Mol Ther Oncolytics 20:342\u2013351. https:\/\/doi.org\/10.1016\/j.omto.2021.01.011","journal-title":"Mol Ther Oncolytics"},{"key":"1463_CR43","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1038\/nm.3769","volume":"20","author":"V Ramaswamy","year":"2014","unstructured":"Ramaswamy V, Remke M, Taylor MD (2014) An epigenetic therapy for diffuse intrinsic pontine gliomas. Nat Med 20:1378\u20131379. https:\/\/doi.org\/10.1038\/nm.3769","journal-title":"Nat Med"},{"key":"1463_CR44","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/nbt.2931","volume":"32","author":"D Risso","year":"2014","unstructured":"Risso D, Ngai J, Speed TP, Dudoit S (2014) Normalization of RNA-seq data using factor analysis of control genes or samples. Nat Biotechnol 32:896\u2013902. https:\/\/doi.org\/10.1038\/nbt.2931","journal-title":"Nat Biotechnol"},{"key":"1463_CR45","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK (2010) edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26:139\u2013140. https:\/\/doi.org\/10.1093\/bioinformatics\/btp616","journal-title":"Bioinformatics"},{"key":"1463_CR46","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s10637-012-9822-x","volume":"31","author":"J Rodr\u00edguez-Pascual","year":"2013","unstructured":"Rodr\u00edguez-Pascual J, Sha P, Garc\u00eda-Garc\u00eda E, Rajeshkumar NV, De Vicente E, Quijano Y et al (2013) A preclinical and clinical study of mycophenolate mofetil in pancreatic cancer. Invest New Drugs 31:14\u201319. https:\/\/doi.org\/10.1007\/s10637-012-9822-x","journal-title":"Invest New Drugs"},{"key":"1463_CR47","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00401-013-1218-2","volume":"127","author":"AM Saratsis","year":"2014","unstructured":"Saratsis AM, Kambhampati M, Snyder K, Yadavilli S, Devaney JM, Harmon B et al (2014) Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes. Acta Neuropathol 127:881\u2013895. https:\/\/doi.org\/10.1007\/s00401-013-1218-2","journal-title":"Acta Neuropathol"},{"key":"1463_CR48","doi-asserted-by":"publisher","first-page":"E680","DOI":"10.1093\/neuros\/nyaa301","volume":"87","author":"T Sasaki","year":"2020","unstructured":"Sasaki T, Katagi H, Goldman S, Becher OJ, Hashizume R (2020) Convection-enhanced delivery of enhancer of zeste homolog-2 (EZH2) inhibitor for the treatment of diffuse intrinsic pontine glioma. Neurosurgery 87:E680\u2013E688. https:\/\/doi.org\/10.1093\/neuros\/nyaa301","journal-title":"Neurosurgery"},{"key":"1463_CR49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/s0014-2999(00)00923-7","volume":"412","author":"F Schmidt","year":"2001","unstructured":"Schmidt F, Rieger J, Wischhusen J, Naumann U, Weller M (2001) Glioma cell sensitivity to topotecan: the role of p53 and topotecan-induced DNA damage. Eur J Pharmacol 412:21\u201325. https:\/\/doi.org\/10.1016\/s0014-2999(00)00923-7","journal-title":"Eur J Pharmacol"},{"key":"1463_CR50","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature10833","volume":"482","author":"J Schwartzentruber","year":"2012","unstructured":"Schwartzentruber J, Korshunov A, Liu XY, Jones DT, Pfaff E, Jacob K et al (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482:226\u2013231. https:\/\/doi.org\/10.1038\/nature10833","journal-title":"Nature"},{"key":"1463_CR51","doi-asserted-by":"publisher","DOI":"10.3791\/1992","author":"L Serwer","year":"2010","unstructured":"Serwer L, Hashizume R, Ozawa T, James CD (2010) Systemic and local drug delivery for treating diseases of the central nervous system in rodent models. J Vis Exp. https:\/\/doi.org\/10.3791\/1992","journal-title":"J Vis Exp"},{"key":"1463_CR52","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1093\/brain\/awab020","volume":"144","author":"JM Shireman","year":"2021","unstructured":"Shireman JM, Atashi F, Lee G, Ali ES, Saathoff MR, Park CH et al (2021) De novo purine biosynthesis is a major driver of chemoresistance in glioblastoma. Brain 144:1230\u20131246. https:\/\/doi.org\/10.1093\/brain\/awab020","journal-title":"Brain"},{"key":"1463_CR53","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/978-94-011-3911-3","volume-title":"Purines: basic and clinical aspects","author":"TW Stone","year":"1991","unstructured":"Stone TW, Simmonds HA (1991) Metabolism of endogenous purines. In: Purines: basic and clinical aspects. Springer Netherlands, Dordrecht, pp 251\u2013306. https:\/\/doi.org\/10.1007\/978-94-011-3911-3"},{"key":"1463_CR54","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545\u201315550. https:\/\/doi.org\/10.1073\/pnas.0506580102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1463_CR55","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1158\/1535-7163.Mct-05-0340","volume":"5","author":"N Takebe","year":"2006","unstructured":"Takebe N, Cheng X, Fandy TE, Srivastava RK, Wu S, Shankar S et al (2006) IMP dehydrogenase inhibitor mycophenolate mofetil induces caspase-dependent apoptosis and cell cycle inhibition in multiple myeloma cells. Mol Cancer Ther 5:457\u2013466. https:\/\/doi.org\/10.1158\/1535-7163.Mct-05-0340","journal-title":"Mol Cancer Ther"},{"key":"1463_CR56","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/s43587-021-00122-7","volume":"1","author":"A Taubes","year":"2021","unstructured":"Taubes A, Nova P, Zalocusky KA, Kosti I, Bicak M, Zilberter MY et al (2021) Experimental and real-world evidence supporting the computational repurposing of bumetanide for APOE4-related Alzheimer\u2019s disease. Nat Aging 1:932\u2013947. https:\/\/doi.org\/10.1038\/s43587-021-00122-7","journal-title":"Nat Aging"},{"key":"1463_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/bf00928361","volume":"140","author":"TW Traut","year":"1994","unstructured":"Traut TW (1994) Physiological concentrations of purines and pyrimidines. Mol Cell Biochem 140:1\u201322. https:\/\/doi.org\/10.1007\/bf00928361","journal-title":"Mol Cell Biochem"},{"key":"1463_CR58","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nbt.3772","volume":"35","author":"J Vivian","year":"2017","unstructured":"Vivian J, Rao AA, Nothaft FA, Ketchum C, Armstrong J, Novak A et al (2017) Toil enables reproducible, open source, big biomedical data analyses. Nat Biotechnol 35:314\u2013316. https:\/\/doi.org\/10.1038\/nbt.3772","journal-title":"Nat Biotechnol"},{"key":"1463_CR59","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/path.5665","volume":"254","author":"Q Wang","year":"2021","unstructured":"Wang Q, Guan YF, Hancock SE, Wahi K, van Geldermalsen M, Zhang BK et al (2021) Inhibition of guanosine monophosphate synthetase (GMPS) blocks glutamine metabolism and prostate cancer growth. J Pathol 254:135\u2013146. https:\/\/doi.org\/10.1002\/path.5665","journal-title":"J Pathol"},{"key":"1463_CR60","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/ng.1102","volume":"44","author":"G Wu","year":"2012","unstructured":"Wu G, Broniscer A, McEachron TA, Lu C, Paugh BS, Becksfort J et al (2012) Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 44:251\u2013253. https:\/\/doi.org\/10.1038\/ng.1102","journal-title":"Nat Genet"},{"key":"1463_CR61","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/ng.2938","volume":"46","author":"G Wu","year":"2014","unstructured":"Wu G, Diaz AK, Paugh BS, Rankin SL, Ju B, Li Y et al (2014) The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat Genet 46:444\u2013450. https:\/\/doi.org\/10.1038\/ng.2938","journal-title":"Nat Genet"},{"key":"1463_CR62","doi-asserted-by":"publisher","first-page":"c61","DOI":"10.1159\/000080674","volume":"98","author":"J Wu","year":"2004","unstructured":"Wu J, Jaar BG, Briggs WA, Choi MJ, Kraus ES, Racusen LC et al (2004) High-dose mycophenolate mofetil in the treatment of posttransplant glomerular disease in the allograft: a case series. Nephron Clin Pract 98:c61\u2013c66. https:\/\/doi.org\/10.1159\/000080674","journal-title":"Nephron Clin Pract"},{"key":"1463_CR63","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/s41596-020-00430-z","volume":"16","author":"B Zeng","year":"2021","unstructured":"Zeng B, Glicksberg BS, Newbury P, Chekalin E, Xing J, Liu K et al (2021) OCTAD: an open workspace for virtually screening therapeutics targeting precise cancer patient groups using gene expression features. Nat Protoc 16:728\u2013753. https:\/\/doi.org\/10.1038\/s41596-020-00430-z","journal-title":"Nat Protoc"},{"key":"1463_CR64","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12920-018-0463-6","volume":"12","author":"WZD Zeng","year":"2019","unstructured":"Zeng WZD, Glicksberg BS, Li Y, Chen B (2019) Selecting precise reference normal tissue samples for cancer research using a deep learning approach. BMC Med Genomics 12:21. https:\/\/doi.org\/10.1186\/s12920-018-0463-6","journal-title":"BMC Med Genomics"},{"key":"1463_CR65","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1038\/s41467-020-17512-x","volume":"11","author":"W Zhou","year":"2020","unstructured":"Zhou W, Yao Y, Scott AJ, Wilder-Romans K, Dresser JJ, Werner CK et al (2020) Purine metabolism regulates DNA repair and therapy resistance in glioblastoma. Nat Commun 11:3811. https:\/\/doi.org\/10.1038\/s41467-020-17512-x","journal-title":"Nat Commun"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01463-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-022-01463-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01463-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T16:35:10Z","timestamp":1666542910000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-022-01463-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,23]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1463"],"URL":"https:\/\/doi.org\/10.1186\/s40478-022-01463-z","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,23]]},"assertion":[{"value":"19 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments in this study were approved by the Northwestern University Institutional Animal Care and Use Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared that no competing interests exist.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"150"}}